Mr. Pappajohn served on the Board of Directors of OneroRx from July 2018 until his passing in April 2023. He brought vast amounts of experience to OneroRx, having been involved in over 100 startups, over 50 IPOs and had served as a director of over 40 public companies. Since 1969, he was the President and sole owner of Pappajohn Capital Resources, a venture capital firm, and President and sole owner of Equity Dynamics, Inc., a financial consulting firm. From January 2014 to July 2019 Mr. Pappajohn was Chairman of the Board of Directors of Cancer Genetics, Inc. He received his BSC from the College of Business Administration at the University of Iowa.